Trial intelligence / Profile preview

Concerta in incarcerated adult men with ADHD in Swedish correctional care

2006-002553-80Phase 4Completed

Sponsor
Karolinska University Hospital
Start
May 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, double-blind trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (3 arms), sponsored by Karolinska University Hospital. Primary endpoint: Change in ADHD symptoms. Started May 2006; status: completed.

02

Drugs

methylphenidate
03

Conditions

attention deficit hyperactivity disorder (ADHD)

Beyond the preview

Go deeper on 2006-002553-80.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-002553-80.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call